Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Cancer. 2015 Feb 11;121(11):1800–1808. doi: 10.1002/cncr.29290

Figure 1.

Figure 1

Selection of the study cohort. DLBCL=diffuse large B-cell lymphoma; SEER=Surveillance, Epidemiology, and End Results; HMO=health maintenance organization; CHOP=cyclophosphamide, doxorubicin, vincristine, prednisone; R-CHOP=rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone; CVP=cyclophosphamide, vincristine, prednisone; R-CVP=rituximab, cyclophosphamide, vincristine, prednisone.